Vertex Pharmaceuticals Inc (VRTX) — Capital Reinvestment Ratio
Latest as of March 2026:
0.09x
Vertex Pharmaceuticals Inc (VRTX) has a Capital Reinvestment Ratio of 0.09x as of March 2026, meaning it reinvests 0% of its operating cash flow ($1.43 Billion) in capital expenditures ($133.40 Million). See free cash flow generation of Vertex Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.09x
Capex / Operating Cash Flow
Operating Cash Flow
$1.43 Billion
USD
Capital Expenditures
$133.40 Million
USD
Data as of
Mar 2026
Most recent filing
Vertex Pharmaceuticals Inc Capital Reinvestment Ratio (1993–2025)
This chart tracks Vertex Pharmaceuticals Inc's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Vertex Pharmaceuticals Inc (1993–2025)
Year-by-year Capital Reinvestment Ratio for Vertex Pharmaceuticals Inc from 1993 to 2025. For live market cap and broader valuation context, see VRTX stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | $3.63 Billion | $437.60 Million | ▲ +65.0% |
| 2023 | 0.07x | $3.54 Billion | $258.40 Million | ▲ +47.4% |
| 2022 | 0.05x | $4.13 Billion | $204.70 Million | ▼ -44.2% |
| 2021 | 0.09x | $2.64 Billion | $235.00 Million | ▲ +11.3% |
| 2020 | 0.08x | $3.25 Billion | $259.80 Million | ▲ +66.1% |
| 2019 | 0.05x | $1.57 Billion | $75.45 Million | ▼ -36.1% |
| 2018 | 0.08x | $1.27 Billion | $95.52 Million | ▼ -75.5% |
| 2017 | 0.31x | $844.94 Million | $259.42 Million | ▲ +28.2% |
| 2016 | 0.24x | $236.10 Million | $56.56 Million | ▼ -9.8% |
| 2012 | 0.27x | $267.84 Million | $71.14 Million | ▼ -59.6% |
| 2011 | 0.66x | $143.74 Million | $94.59 Million | ▲ +214.4% |
| 1993 | 0.21x | $8.60 Million | $1.80 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow